Assessment of biomarkers in asbestos-exposed workers as indicators of cancer risk

Mutat Res. 2008 Aug-Sep;655(1-2):52-8. doi: 10.1016/j.mrgentox.2008.06.011.

Abstract

Epidemiological studies have shown that mortality from malignant mesothelioma (MM) and lung cancer have increased with increasing cumulative exposure to asbestos. To investigate whether tumour-related biomarkers can contribute towards the evaluation of the carcinogenic risk in populations exposed to asbestos, the DNA adduct 8-hydroxy-2'-deoxyguanosine (80HdG), interleukine-6 (IL-6), platelet-derived growth factor (PDGF-BB), hepatocyte growth factor (HGF), basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGFbeta) and soluble mesothelin-related peptides (SMRPs) were analysed in a cohort of workers differently exposed to asbestos fibres at the workplace. To document biomarker levels in an unexposed population, 54 age-matched subjects were enrolled. A total of 119 subjects with a history of occupational exposure to asbestos underwent clinical examination and were interviewed by trained personnel, responding to a detailed questionnaire related to duration of asbestos exposure, smoking, and occupational task. According to the occupational tasks, asbestos-exposed subjects were analysed for their asbestos cumulative dose and the association with the biomarkers was evaluated. Among the occupational groups, maintenance workers, pipe fitters and electricians were exposed to a higher cumulative dose of asbestos fibres. Exposure to asbestos significantly increased the steady-state content of 80HdG in DNA. Elevated levels of 80HdG and IL-6 best reflected a high level of SMRPs, which is related to cell transformation. Subjects heavily exposed to asbestos [> 60(ff/cm3) x years] showed also a higher level of angiogenic factors. A combination of angiogenic biomarkers with a specific mesothelioma-biomarker such as SMRPs could be used for close surveillance of workers with a history of asbestos exposure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Asbestos / adverse effects*
  • Biomarkers, Tumor / analysis
  • Biomarkers, Tumor / blood*
  • Female
  • Humans
  • Lymphocytes / metabolism
  • Male
  • Mesothelioma / blood*
  • Mesothelioma / diagnosis
  • Mesothelioma / prevention & control
  • Middle Aged
  • Occupational Diseases / blood*
  • Occupational Diseases / diagnosis
  • Occupational Diseases / prevention & control
  • Occupational Exposure*
  • Pleural Neoplasms / blood*
  • Pleural Neoplasms / diagnosis
  • Pleural Neoplasms / prevention & control
  • Regression Analysis
  • Risk Factors

Substances

  • Biomarkers, Tumor
  • Asbestos